The FDA has approved the first at-home brain stimulation device for treating depression. Flow Neuroscience’s FL-100 delivers ...

FRIDAY, Dec. 12, 2025 (HealthDay News) — An at-home device that sends a gentle electrical current to the brain to help treat depression has been cleared by the U.S. Food and Drug Administration (FDA).

An in-home headset that allows people with depression to send mild electrical current to their brains has been cleared by the ...

SPRAVATO is the first FDA-approved nasal spray specifically for adults with treatment-resistant depression. Available with a ...

Sutter Health will be the first healthcare system in the Sacramento area to offer SAINT, a new accelerated version of ...

Unlike commonly used oral antidepressants (often known as selective serotonin reuptake inhibitors or SSRIs), ketamine works through a different mechanism. It targets glutamate pathways in the brain, ...

BOSTON, Oct. 13, 2025 /PRNewswire/ -- Zeta Surgical today announced that its Zeta TMS Navigation System has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). The device is ...

BrainsWay Ltd. BWAY recently secured FDA clearance for an accelerated treatment protocol using its Deep Transcranial Magnetic Stimulation (TMS) system. The approval allows providers to treat patients ...

A more precise and personalized form of electric brain stimulation may be a more effective and faster treatment for people with moderate to major depression compared to other similar treatments, ...